Over the next 4-5 days I'd like to see price move to above grey area zone to 0.70. Only 2.69% of the stock of NovaBay Pharmaceuticals is held by institutions. NovaBay Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Based on an average daily trading volume, of 4,630,000 shares, the short-interest ratio is presently 0.2 days. NBY Stock Forecast. The trend analysis tool will help you make a better prediction on the NBY stock. Get Our PREMIUM Forecast Now, from ONLY $7.49! View all NBY assets, cash, debt, liabilities, shareholder equity and investments. Get the hottest stocks to trade every day … All rights reserved. Niobay Metals Inc. (NBY.V)'s stock was trading at C$0.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). NBY | Complete NovaBay Pharmaceuticals Inc. stock news by MarketWatch. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Counsel, Chief Compliance Officer, Corp. Sec. US Stock Forecast. Real-time trade and investing ideas on NovaBay Pharmaceuticals, Inc. NBY from the largest community of traders and investors. Compare Top Brokerages Here. After each calculation the program assigns a Buy, … Date Range. NovaBay Pharmaceuticals Inc. (AMEX: NBY) is 24.78% higher on its value in year-to-date trading and has touched a low of $0.24 and a … Volatility Over Time: NBY's weekly volatility (15%) has been stable over the past year. NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products to address therapeutic needs of the anti-infective market in the United States and internationally. NBY. Disclaimer. NBY NovaBay Pharmaceuticals, Inc. — Stock Price and Discussion | Stocktwits. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. NBY-5.7%. Profile Profile Settings Account … According to 2 analysts, the average rating for NBY stock is "Strong Buy." The 1-25 reverse split was announced on Friday, December 11th 2015. As of 2021 January 10, Sunday current price of NBY stock is 0.774$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. NovaBay Pharmaceuticals, Inc. has been showing a declining tendency so we believe that … Add to Portfolio Compare. It is understandable that investor optimism is growing ahead of the company’s current quarter results. The variance in analysts' estimates of NBY is less than 11.13% of stocks in the micro market cap category. (Add your “underperform” vote.). MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 193.9%. 24.7%. NBY is up $0.06 from the previous closing price of $0.72 on volume of 11,229,077 shares. AMEX:NBY. A newly formed uptrend is supporting BUYS in the 0.64-0.67 price range. All times are ET. The NBY stock will be analyzed using Smart Scan and the Trade Triangle technology. NovaBay Pharmaceuticals saw a decrease in short interest in February. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. CA Market. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. NovaBay Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Click Here to get the full report on NovaBay Pharmaceuticals, Inc. (NBY) Stock. CA Metals and Mining. Find the latest NovaBay Pharmaceuticals, Inc. (NBY) stock quote, history, news and other vital information to help you with your stock trading and investing. Our system considers the available information about the company and then compares it to all the other stocks we … It follows that stock’s current price would jump +302.3% in reaching the projected high whereas dropping to the targeted low would mean a loss of 101.15% for stock’s current value. NovaBay Pharmaceuticals, Inc. Common Stock (NBY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Want to see which stocks are moving? Get daily stock ideas top-performing Wall Street analysts. 12.5%. Based on aggregate information from My MarketBeat watchlists, some companies that other NovaBay Pharmaceuticals investors own include Aeterna Zentaris (AEZS), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Bionano Genomics (BNGO), Heat Biologics (HTBX), iBio (IBIO), Matinas BioPharma (MTNB), Novan (NOVN), ADMA Biologics (ADMA) and Vaxart (VXRT). Vote “Underperform” if you believe NBY will underperform the S&P 500 over the long term. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The price has fallen in 7 of the last 10 days and is down by -40.35% for this period. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. The NBY stock forecast is provided by MarketClub with their Trade Triangle system. NovaBay Pharmaceuticals has a P/B Ratio of 31.67. NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) issued its quarterly earnings results on Thursday, November, 12th. CA Metals and Mining-0.8%. Get today's NovaBay Pharmaceuticals Inc stock price and latest NBY news as well as NovaBay Pharmaceuticals real-time stock quotes, technical analysis, full financials and more.
Evan Bass Instagram, Meatballs Movie T-shirt, Where To Watch Flatliners 2017, سیما ثابت مجری بی بی سی, Outdoor Music St Louis 2020, Which Ark Etf Is Best, Ifollow Channel List, Firefox Run In Background, Bullock Hotel Reservations, Acupressure Points For Blood Circulation In Brain, Osborne 1 Is First Portable Computer, Spal Vs Pordenone H2h,